Evidence map›Paper›PMID 19752233›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Improved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).

Alexander Zarbock, Matthew R Distasi, Emily Smith, John M Sanders, Gerhard Kronke, Brian L Harry, Sibylle von Vietinghoff, Konrad Buscher, Jerry L Nadler, Klaus Ley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Alexander ZarbockRobert M. Berne Cardiovascular Research Center, Department of Anesthesiology and Critical Care Medicine, University of Muenster, Albert-Schweitzer Strasse 33, Muenster 48149, Germany. zarbock@uni-muenster.de
Matthew R Distasi
Emily Smith
John M Sanders
Gerhard Kronke
Brian L Harry
Sibylle von Vietinghoff
Konrad Buscher
Jerry L Nadler
Klaus Ley
Cardiovascular Research Center · BRLa Jolla Institute for Immunology · USUniversity of Münster · DE

Funding

ROLE OF LIPOXYGENASES IN ATHEROGENESIS IN DIABETES MELLITUSP01HL055798 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HEDRICK, CATHERINE C · 1995 to 2016
$28.4M
Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
ROLE OF INFLAMMATION IN PULMONARY INJURYP01HL073361 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MEHRAD, BORNA · 2004 to 2008
$8.0M
NHLBI NIH HHS P01 HL055798NHLBI NIH HHS P01 HL073361NHLBI NIH HHS P01 HL 73361NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Acute lung injury (ALI) is a prevalent disease associated with high mortality. 12/15-lipoxygenase (12/15-LO) is an enzyme producing 12-hydroxyeicosatetraenoic acid (HETE) and 15-HETE from arachidonic acid. To test whether 12/15-LO is involved in increasing vascular permeability in the lung, we investigated the role of 12/15-LO in murine models of LPS-induced pulmonary inflammation and clinically relevant acid-induced ALI. The vascular permeability increase upon LPS inhalation was abolished in Alox15(-/-) mice lacking 12/15-LO and in wild-type mice after pharmacological blockade of 12/15-LO. Alox15(-/-) mice also showed improved gas exchange, reduced permeability increase, and prolonged survival in the acid-induced ALI model. Bone marrow chimeras and reconstitution experiments revealed that 12-HETE produced by hematopoietic cells regulates vascular permeability through a CXCR2-dependent mechanism. Our findings suggest that 12/15-LO-derived 12-HETE is a key mediator of vascular permeability in acute lung injury.

Indexed as

Lipoxygenase Inhibitors12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAcute Lung InjuryAnimalsArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseCaffeic AcidsCapillary PermeabilityCells, CulturedDisease Models, AnimalHumansInflammation MediatorsLipopolysaccharidesMiceMice, Inbred BALB CMice, Inbred C57BL12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAlox15 protein, mouseArachidonate 12-LipoxygenaseArachidonate 15-LipoxygenaseCaffeic Acidscinnamyl-3,4-dihydroxycyanocinnamateInflammation MediatorsLipopolysaccharidesLipoxygenase InhibitorsMultienzyme Complexes

Identifiers

PMID19752233
PMCPMC2753988
OpenAlexW1774666547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.